RxDoctor Payments Data

Jennifer James, APRN

Family · Fort Worth, TXNPI 1396331724

Payments from drug & device makers

$676in general payments, 2019–2025

Across 34 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$200
  • AbbVie$143
  • Amarin Pharma, Inc.$70
  • Lilly USA, LLC$45
  • Novo Nordisk$44
  • Pfizer$37
  • plus $138 from 6 others

What the payments were for

  • Food & beverage$676100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$676 in reported general payments places this provider in the 60th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Medicare billing

Part B allowed, 2024
$4,403
Medicare patients
19
Services billed
119

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide67$136,389
MounjaroTirzepatide27$55,731
JanuviaSitagliptin Phosphate28$42,225
JardianceEmpagliflozin18$23,353
RybelsusSemaglutide13$22,005
EliquisApixaban11$21,549
Bydureon BciseExenatide Microspheres13$17,063
XareltoRivaroxaban11$16,445
SymbicortBudesonide/Formoterol Fumarate18$11,457
Varenicline Tartrate15$4,205
Albuterol Sulfate HfaAlbuterol Sulfate141$3,694
Gabapentin114$2,850
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$1,689
Nano 2nd Gen Pen NeedlePen Needle, Diabetic16$1,589
Clobetasol Propionate13$1,584

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$44$158,39480 claims
Lilly USA, LLCMounjaro$45$55,73127 claims
PfizerEliquis$37$21,54911 claims
Johnson & JohnsonXarelto$14$16,44511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 15,456 family providers in Texas.

Other family in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →